- Home
- EXEL vs LBTYK Comparison
EXEL vs LBTYK Comparison
Compare EXEL & LBTYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- LBTYK
- Stock Information
- Founded
- EXEL 1994
- LBTYK 2004
- Country
- EXEL United States
- LBTYK Bermuda
- Employees
- EXEL N/A
- LBTYK N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- LBTYK Cable & Other Pay Television Services
- Sector
- EXEL Health Care
- LBTYK Telecommunications
- Exchange
- EXEL Nasdaq
- LBTYK Nasdaq
- Market Cap
- EXEL 9.7B
- LBTYK 4.5B
- IPO Year
- EXEL 2000
- LBTYK N/A
- Fundamental
- Price
- EXEL $34.45
- LBTYK $12.45
- Analyst Decision
- EXEL Buy
- LBTYK
- Analyst Count
- EXEL 18
- LBTYK 0
- Target Price
- EXEL $31.72
- LBTYK N/A
- AVG Volume (30 Days)
- EXEL 2.6M
- LBTYK 1.6M
- Earning Date
- EXEL 10-29-2024
- LBTYK 01-01-0001
- Dividend Yield
- EXEL N/A
- LBTYK N/A
- EPS Growth
- EXEL 441.02
- LBTYK N/A
- EPS
- EXEL 1.55
- LBTYK N/A
- Revenue
- EXEL $2,081,598,000.00
- LBTYK $7,674,500,000.00
- Revenue This Year
- EXEL $20.53
- LBTYK $0.23
- Revenue Next Year
- EXEL $1.54
- LBTYK $0.93
- P/E Ratio
- EXEL $22.26
- LBTYK N/A
- Revenue Growth
- EXEL 17.31
- LBTYK 3.53
- 52 Week Low
- EXEL $19.20
- LBTYK $11.25
- 52 Week High
- EXEL $36.60
- LBTYK $22.14
- Technical
- Relative Strength Index (RSI)
- EXEL 67.10
- LBTYK 16.40
- Support Level
- EXEL $27.86
- LBTYK $11.25
- Resistance Level
- EXEL $36.49
- LBTYK $12.85
- Average True Range (ATR)
- EXEL 0.98
- LBTYK 0.62
- MACD
- EXEL -0.01
- LBTYK -1.00
- Stochastic Oscillator
- EXEL 74.10
- LBTYK 11.54
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About LBTYK Liberty Global Ltd. Class C
Liberty Global is a holding company with interests in several telecom companies in the U.K., Netherlands, Belgium, Switzerland, Ireland, and Slovakia. Liberty is the owner of the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile-network-operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.